# Weitao Zhuang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/weitao-zhuang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 636 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 14 |
| i10-index | 20 |
| Last Known Institution | First Affiliated Hospital of Guangzhou Medical University |
| OpenAlex ID | https://openalex.org/A5049649457 |
| ORCID iD | 0000-0002-8679-4109 |
| Works | 107 |

## Researcher papers

- [Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study](https://scholariq.org/papers/discovery-and-validation-of-methylation-signatures-in-circulating-cell-free-dna/)
- [Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer](https://scholariq.org/papers/cell-free-dna-from-bile-outperformed-plasma-as-a-potential-alternative-to-tissue/)
- [EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47](https://scholariq.org/papers/egfr-oncogenic-mutations-in-nsclc-impair-macrophage-phagocytosis-and-mediate/)
- [Modified rehabilitation exercises for mild cases of COVID-19](https://scholariq.org/papers/modified-rehabilitation-exercises-for-mild-cases-of-covid-19/)
- [Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy](https://scholariq.org/papers/mex-3-rna-binding-family-member-a-mex3a-circmpp6-complex-promotes-colorectal/)
- [Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma—A Real-World Multicenter Study (RICE-Retro)](https://scholariq.org/papers/conversion-surgery-following-immunochemotherapy-in-initially-unresectable/)
- [Exploration of immunotherapy in advanced pulmonary lymphoepithelioma‐like carcinoma](https://scholariq.org/papers/exploration-of-immunotherapy-in-advanced-pulmonary-lymphoepithelioma-like/)
- [Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods](https://scholariq.org/papers/rare-smarca4-deficient-thoracic-tumor-insights-into-molecular-characterization/)
- [Misconception contributed to COVID-19 vaccine hesitancy in patients with lung cancer or ground-glass opacity: a cross-sectional study of 324 Chinese patients](https://scholariq.org/papers/misconception-contributed-to-covid-19-vaccine-hesitancy-in-patients-with-lung/)
- [Utility of feeding jejunostomy in patients with esophageal cancer undergoing esophagectomy with a high risk of anastomotic leakage](https://scholariq.org/papers/utility-of-feeding-jejunostomy-in-patients-with-esophageal-cancer-undergoing/)
- [Rare transformation from lung adenocarcinoma to sarcomatoid carcinoma mediates resistance to inhibitors targeting different driver oncogenes](https://scholariq.org/papers/rare-transformation-from-lung-adenocarcinoma-to-sarcomatoid-carcinoma-mediates/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [First Affiliated Hospital of Guangzhou Medical University](https://scholariq.org/institutions/first-affiliated-hospital-of-guangzhou-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.